2,9-dimethyl-beta-carbolinium and Parkinsonian Disorders

2,9-dimethyl-beta-carbolinium has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kuter, K; Lorenc-Koci, E; Ossowska, K; Rommelspacher, H; Schulze, G; Smiałowska, M; Wernicke, C; Wierońska, J; Zieba, B	1

Other Studies

1 other study(ies) available for 2,9-dimethyl-beta-carbolinium and Parkinsonian Disorders

Article	Year
Parkinson's disease-like syndrome in rats induced by 2,9-dimethyl-beta-carbolinium ion, a beta-carboline occurring in the human brain. Behavioural pharmacology, 2006, Volume: 17, Issue:5-6 Topics: Animals; Carbolines; Cell Count; Corpus Striatum; Dominance, Cerebral; Dopamine; Dose-Response Relationship, Drug; Electromyography; Humans; Male; Muscle Tonus; Neural Pathways; Neurons; Neurotoxins; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase	2006

Article

Year

Parkinson's disease-like syndrome in rats induced by 2,9-dimethyl-beta-carbolinium ion, a beta-carboline occurring in the human brain.

Behavioural pharmacology, 2006, Volume: 17, Issue:5-6

Topics: Animals; Carbolines; Cell Count; Corpus Striatum; Dominance, Cerebral; Dopamine; Dose-Response Relationship, Drug; Electromyography; Humans; Male; Muscle Tonus; Neural Pathways; Neurons; Neurotoxins; Parkinsonian Disorders; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase

2006